corporate spinoff

Abbott to spin off nutrition unit, cuts sales outlook

Abbott Laboratories said Wednesday it plans to separate its Nutrition business, the maker of Similac, Ensure, PediaSure, Pedialyte and Glucerna, into an independent publicly traded company by the end of 2027. Abbott said in its announcement that the unit has…